NVVE — what changed in the latest 10-Q
A section-by-section comparison of NVVE's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-08-14 vs the prior 10-Q · 2026-07-15
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +43 | −22 | ~15 | 21 |
| Controls & procedures | Text added/removed | +1 | −3 | ~2 | 0 |
| Legal proceedings | No paragraph-level changes | 0 | 0 | 0 | 2 |
| Risk factors | Text added/removed | +9 | −11 | ~4 | 1 |
| Other information | Text added/removed | 0 | 0 | ~1 | 0 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Not shown (absent or not faithfully extractable): Market risk (Item 3)
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-08-14
June Special Meeting, our stockholders approved the issuance of the Preferred Stock Consideration, subject to completion of the requisite milestones, per the Cooperation Agreement. As of June 30, 2026, none of the Common Stock Consideration or Preferred Stock Consideration had been issued.
Total revenue was $1.23 million for the three months ended June 30, 2026, compared to $0.33 million for the three months ended June 30, 2025, an increase of $0.89 million, or 268.4%. The increase was primarily attributable to $0.77 million increase in products revenue due to higher customers sales o…
Three Months June 30, 2026 compared to Three Months Ended June 30, 2025
Cost of products and services revenue was $1.19 million for the three months ended June 30, 2026, compared to $0.13 million for the three months ended June 30, 2025, an increase of $1.06 million, or 811.7%. The increase was primarily due to higher costs of products revenue driven primarily by higher…
Products margin decreased by 50.0% to 16.1% for the three months ended June 30, 2026, compared to 66.1% in the same prior year period driven by higher replacement warranty costs of certain discontinued DC Chargers in the current quarter.
Text removed vs the prior filing · source: 10-Q · 2026-07-15
operational milestones, shares of Series B Convertible Preferred Stock of Nuvve (the “Preferred Stock Consideration”). At the June Special Meeting, our stockholders approved the issuance of the Preferred Stock Consideration, subject to completion of the requisite milestones, per the Cooperation Agre…
Less: Net loss attributable to non-controlling interests(432,936)(5,598)(427,338)NM
Cost of products and services revenue was $0.74 million for the three months ended March 31, 2026, compared to $0.56 million for the three months ended March 31, 2025, an increase of $0.18 million, or 32.2%. The increase was primarily due to higher costs of products revenue driven primarily by highe…
Products margin decreased by 44.8% to negative 32.0% for the three months ended March 31, 2026, compared to 12.8% in the same prior year period driven by higher replacement warranty costs of certain discontinued DC Chargers in the current quarter. Services margin increased by 2.8% to 77.3% for the t…
Products and services margin increased by 2.7% to 35.3% for the three months ended March 31, 2026, compared to 32.6% in the same prior year period. Margin was positively impacted by higher mix of engineering services, and a lower mix of hardware charging stations partially offset by higher replaceme…
Controls & procedures
Text added vs the prior filing · source: 10-Q · 2026-08-14
Other than the ongoing remediation of the previously identified material weakness as disclosed in our quarterly report for the three months ended March 31, 2026, there has been no change in our internal control over financial reporting during the quarter ended June 30, 2026, that has materially affe…
Text removed vs the prior filing · source: 10-Q · 2026-07-15
Under the direction of our principal executive officer and principal financial and accounting officer, we are developing a plan to remediate the material weaknesses.
Our management is committed to maintaining a strong internal control environment. In response to the material weakness described above, we are in process of implementing a number of remedial actions, including (i) pursuing the expansion of our legal and accounting personnel, (ii) enhancing disclosur…
Other than the identification of and remedial actions with respect to the material weakness described above, there has been no change in our internal control over financial reporting during the quarter ended March 31, 2026, that has materially affected, or is reasonably likely to materially affect, …
Risk factors
Text added vs the prior filing · source: 10-Q · 2026-08-14
Trading of our Common Stock on The Nasdaq Capital Market was suspended on July 24, 2026 due to our failure to meet Nasdaq’s continued listing requirements, and our Common Stock now trades on the OTCQB. This transition has resulted, and may continue to result, in a decrease in the market price of our…
On July 22, 2026, we received a written notification (the “Delisting Notice”) from Nasdaq that the Nasdaq Hearings Panel (the “Panel”) had determined to delist our Common Stock from The Nasdaq Capital Market due to our failure to demonstrate compliance with (i) the filing requirement set forth in Na…
On July 24, 2026, our Common Stock commenced trading on the OTC Pink Limited Market, an over-the-counter market operated by OTC Markets Group. Effective August 10, 2026, our Common Stock commenced trading on the OTCQB tier of the OTC Markets, where it currently trades under the symbol “NVVE.” This t…
Although our Common Stock is quoted on the OTCQB, the suspension of trading in our Common Stock on Nasdaq limits the public resale market for our Common Stock. The lack of an active, liquid trading market for our Common Stock could impair your ability to sell your shares at the time you wish to sell…
Our Common Stock may be considered a penny stock and we may be subject to certain restrictions on the marketability of our Common Stock.
Text removed vs the prior filing · source: 10-Q · 2026-07-15
If we are unable to maintain compliance with the Nasdaq Stock Market’s listing requirements, our common stock may be delisted from the Nasdaq Capital Market, which could have a material adverse effect on our financial condition and could make it more difficult for holders of our common stock to sell…
Our common stock is currently listed on the Nasdaq Capital Market and is therefore subject to the continued listing requirements of the Nasdaq Capital Market, including requirements with respect to the market value of publicly held shares, market value of listed shares, minimum bid price per share, …
On January 6, 2026, we received a letter from Nasdaq stating that the Nasdaq Hearings Panel had found us to be in compliance with the Stockholders’ Equity Rule and Bid Price Rule. The letter also indicated that we are subject to a Mandatory Panel Monitor for a period of one year commencing on Januar…
On April 20, 2026, we received a letter from Nasdaq (the “April Notice”) stating that, because the closing price for our common stock had fallen below $1.00 per share for 30 consecutive trading days, we were no longer in compliance with the Bid Price Rule. Further, the April Notice stated that, purs…
period specified in Rule 5810(c)(3)(A) due to the fact that we had effected a reverse stock split over the prior one-year period and had effected one or more reverse stock splits over the prior two-year period with a cumulative ratio of 250 shares or more to one.
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice